ASCO GUIDELINES Bundle

Estrogen and Progesterone Receptor Testing in Breast Cancer

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1199868

Contents of this Issue

Navigation

Page 3 of 13

4 Diagnosis Recommendation 1.4. Optimal internal validation procedures (change anticipated) ➤ This topic is deferred to forthcoming CAP guideline update, Principles of Analytic Validation of IHC Assays, once available. There should be initial test validation/verification prior to reporting any clinical samples. Prior to that, previously recommended principles apply. (Strong Recommendation; EB-H) Recommendation 1.5. Optimal internal QA procedures ➤ Ongoing quality control and equipment maintenance are required. Initial and ongoing laboratory personnel training and competency assessment should be performed. Standardized operating procedures should be used that include routine use of external control materials with each batch of testing and routine evaluation of internal normal epithelial elements or the inclusion of normal breast sections (or other appropriate control) on each tested slide, wherever possible. External controls should include negative and positive samples as well as samples with lower percentages of ER expression (such as tonsil). On slide controls are recommended. Regular, ongoing assay reassessment should be done at least semiannually. Revalidation is needed whenever there is a significant change to the test system. Ongoing competency assessment and education of pathologists is required. (Strong Recommendation; EB-H) Recommendation 1.6. Optimal external proficiency assessment ➤ The laboratory performing ER and PgR testing must participate in external proficiency testing or alternative performance assessment as required by its accrediting organization. (Strong Recommendation; EB-H) Recommendation 1.7. Optimal laboratory accreditation ➤ On-site inspection every other year should be undertaken with annual requirement for self-inspection. (Moderate Recommendation; IC-I) Recommendation 2.1 ➤ Laboratories should include ongoing quality control using standard operating procedures for test evaluation prior to scoring (readout) and interpretation of any case as defined in the checklist in Figure 1. (Strong Recommendation; IC-H)

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Estrogen and Progesterone Receptor Testing in Breast Cancer